HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
BIOBOARD - NORTH AMERICA
Biologics and stem cell research boost the cell culture market
Cell culture is becoming the next big pharmaceutical trend, as laboratories rush to meet demand for stem cell and biologics, states a new report by healthcare experts GBI Research.

The new report, entitled “Cell Culture — Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities”, looks at cell culture, which involves the isolation of animal or plant cells, for their growth in an artificial environment where conditions such as temperature and pressure are all controlled.

Manufacturing of biopharmaceuticals involves cell culture methods, and the growing trend for biologics will boost the demand for cell culture processing. Biopharmaceuticals are target-specific molecules which are less toxic and more effective than small molecular entities, and are in high demand for the treatment of cancer, diabetes, and arthritis, attracting the focus of many major pharmaceutical companies.

Due to their unique method of development, biopharmaceutical products are not easy to be imitated by generic forms. R&D in the sector is largely devoted to deriving novel mechanisms of action, and increasing access to newer treatments to produce potential cures and improve the quality of life for people suffering from various diseases and conditions. This focus helps in generating better treatment options and earning higher revenues for pharmaceutical and biotechnological companies. The development and manufacturing of these biological products is directly related to the growing demand for cell culture.

Stem cell research also has enormous potential for cell culture. Cell culture methods ensure standardized production and propagation of highly purified stem cells and their differentiated progeny. Conventional therapies manage the disease symptoms, while stem cell therapies treat the cause of the disease, and from a commercial perspective this deficit of curative treatments in conventional therapies makes stem cell research a potential goldmine. In the past few years, stem cell research has gained more importance in cancer research, though the technique still faces many unresolved risks including the uncontrolled proliferation of transplanted cells and transmission of infectious agents.

The cell culture market has more than 90% of its products manufactured by a small number of players, including EMD Millipore, Life Technologies Corporation, Sigma-Aldrich Corporation and Thermo Fisher Scientific Inc. A significant number of small players are also entering into the market, especially in emerging countries. However, tough industry regulations limit the speed at which these companies can progress. The cell culture process requires precise handling, with any changes affecting the safety and efficacy profile of the final product. As a result of this, the processes used for cell culturing are constrained by strict controls, which slow down development and act as a bottleneck to progression in cell culture processing techniques.

The global cell culture market was worth US$3.4 billion in 2011, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 9.3% between 2011 and 2018 to reach US$6.3 billion in 2018.

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy